Inventor · disambiguated record
Ashok Arasappan
Also filed as: ARASAPPAN ASHOK
47 granted patents·11 pending applications·1,543 citations·filing 2001–2024
98Inventor score
Files withSCHERING CORP22MERCK SHARP & DOHME14MERCK SHARP & DOHME LLC6DENDREON CORP5ARASAPPAN ASHOK3
Top patents by PatentIndex Score
58 records- 0198US6838475B2Imidazolidinones as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jan 4, 2005·121 cites·43 claims
- 0297US7012066B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Mar 14, 2006·176 cites·64 claims
- 0396US7186747B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 6, 2007·47 cites·31 claims
- 0496US6911428B2Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jun 28, 2005·124 cites·20 claims
- 0596US6800434B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Oct 5, 2004·89 cites·1 claims
- 0695US7592316B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2007·Granted Sep 22, 2009·34 cites·6 claims
- 0795US7425576B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted Sep 16, 2008·20 cites·24 claims
- 0895US7205330B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2005·Granted Apr 17, 2007·54 cites·29 claims
- 0995US7173057B2Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virusSCHERING CORP·Filed 2005·Granted Feb 6, 2007·44 cites·29 claims
- 1095US7169760B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Jan 30, 2007·88 cites·30 claims
- 1195US6846802B2Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moietiesSCHERING CORP·Filed 2001·Granted Jan 25, 2005·124 cites·21 claims
- 1294US9156872B22′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 13, 2015·45 cites·21 claims
- 1394US9061041B22′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Jun 23, 2015·49 cites·43 claims
- 1494US8697694B2Substituted pyridine and pyrimidine derivatives and their use in treating viral infectionsARASAPPAN ASHOK·Filed 2009·Granted Apr 15, 2014·52 cites·7 claims
- 1594US7423058B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2006·Granted Sep 9, 2008·15 cites·22 claims
- 1694US7244721B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2002·Granted Jul 17, 2007·80 cites·67 claims
- 1794US6914122B2Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moietiesSCHERING CORP·Filed 2001·Granted Jul 5, 2005·89 cites·36 claims
- 1893US7342041B23,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 11, 2008·28 cites·34 claims
- 1993US7192957B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 20, 2007·28 cites·28 claims
- 2092US8541434B2Ethynyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infectionsKWONG CECIL D·Filed 2009·Granted Sep 24, 2013·39 cites·17 claims
- 2192US7399749B2Substituted prolines as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Jul 15, 2008·21 cites·26 claims
- 2292US6894072B2Compounds as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2003·Granted May 17, 2005·59 cites·25 claims
- 2391US11377438B22-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jul 5, 2022·6 cites·22 claims
- 2490US9408863B25′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseasesVERMA VISHAL A·Filed 2012·Granted Aug 9, 2016·13 cites·12 claims
- 2589US9290517B2Azabenzimidazole hexahydrofuro[3,2-b]furan derivativesMERCK SHARP & DOHME·Filed 2013·Granted Mar 22, 2016·8 cites·20 claims
- 2689USRE43298EPeptides as NS3-serine protease inhibitors of hepatitis C virusSAKSENA ANIL K·Filed 2011·Granted Apr 3, 2012·17 cites·66 claims
- 2788US7485625B2Inhibitors of hepatitis C virus NS3/NS4a serine proteaseSCHERING CORP·Filed 2004·Granted Feb 3, 2009·33 cites·35 claims
- 2886US7816326B2Sulfur compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2007·Granted Oct 19, 2010·9 cites·18 claims
- 2983US8067379B2Sulfur compounds as inhibitors of hepatitis C virus NS3 serine proteaseBENNETT FRANK·Filed 2005·Granted Nov 29, 2011·8 cites·43 claims
- 3082US7619094B2Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virusSCHERING CORP·Filed 2006·Granted Nov 17, 2009·5 cites·33 claims
- 3181US11028092B2Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jun 8, 2021·2 cites·24 claims
- 3280US2025084064A12-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 3378US10934294B2Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Mar 2, 2021·2 cites·13 claims
- 3478US9868733B2Azabenzimidazole tetrahydrofuran derivativesMERCK SHARP & DOHME·Filed 2013·Granted Jan 16, 2018·4 cites·15 claims
- 3577US9556193B2Benzimidazole hexahydrofuro[3,2-b]furan derivativesMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·4 cites·16 claims
- 3676US9416154B25′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesVERMA VISHAL A·Filed 2012·Granted Aug 16, 2016·4 cites·19 claims
- 3772US12195445B22-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 14, 2025·0 cites·15 claims
- 3872US2022218676A1CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USEMERCK SHARP & DOHME·Filed 2022·Application pending·0 cites
- 3970US2023312528A12-oxo-imidazolidine-4-carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 4069US10806724B2Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2019·Granted Oct 20, 2020·0 cites·12 claims
- 4167US10072003B2Tetrahydronaphthyridine derivatives as mGluR2-negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2015·Granted Sep 11, 2018·1 cites·8 claims
- 4265US2021015800A1CHROMANE, ISOCHROMANE AND DIHYDROISOBENZOFURAN DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USEMERCK SHARP & DOHME·Filed 2020·Application pending·0 cites
- 4364US10335399B2Chromane, isochromane and dihydroisobenzofuran derivatives as mGluR2—negative allosteric modulators, compositions, and their useMERCK SHARP & DOHME·Filed 2017·Granted Jul 2, 2019·0 cites·28 claims
- 4464US9433621B2Substituted pyridine and pyrimidine derivatives and their use in treating viral infectionsARASAPPAN ASHOK·Filed 2011·Granted Sep 6, 2016·1 cites·7 claims
- 4562US11802122B22-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Oct 31, 2023·0 cites·46 claims
- 4658US7718691B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted May 18, 2010·0 cites·33 claims
- 4757US2006205672A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2005·Application pending·0 cites
- 4856US7759499B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted Jul 20, 2010·0 cites·22 claims
- 4956US2022380338A1Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 5056US2024246932A1Aryl 3-oxopiperazine carboxamides and heteroaryl 3-oxopiperazine carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ashok Arasappan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →